Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1987 4
1988 1
1989 5
1990 1
1991 2
1996 2
1998 1
1999 2
2000 2
2001 2
2002 1
2005 1
2006 7
2007 7
2008 7
2009 7
2010 13
2011 8
2012 7
2013 2
2014 2
2015 6
2016 3
2017 3
2018 5
2019 1
2020 1
2021 2
2022 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.
Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T, Voskaridou E, Liew HK, Pazgal-Kobrowski I, Forni GL, Perrotta S, Khelif A, Lal A, Kattamis A, Vlachaki E, Origa R, Aydinok Y, Bejaoui M, Ho PJ, Chew LP, Bee PC, Lim SM, Lu MY, Tantiworawit A, Ganeva P, Gercheva L, Shah F, Neufeld EJ, Thompson A, Laadem A, Shetty JK, Zou J, Zhang J, Miteva D, Zinger T, Linde PG, Sherman ML, Hermine O, Porter J, Piga A; BELIEVE Investigators. Cappellini MD, et al. N Engl J Med. 2020 Mar 26;382(13):1219-1231. doi: 10.1056/NEJMoa1910182. N Engl J Med. 2020. PMID: 32212518 Clinical Trial.
Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study.
Robak T, Jin J, Pylypenko H, Verhoef G, Siritanaratkul N, Drach J, Raderer M, Mayer J, Pereira J, Tumyan G, Okamoto R, Nakahara S, Hu P, Appiani C, Nemat S, Cavalli F; LYM-3002 investigators. Robak T, et al. Lancet Oncol. 2018 Nov;19(11):1449-1458. doi: 10.1016/S1470-2045(18)30685-5. Epub 2018 Oct 19. Lancet Oncol. 2018. PMID: 30348538 Clinical Trial.
Primary adrenal lymphoma.
Kacem K, Zriba S, Lakhal RB, Bouteraa W, Aissaoui L, Amor RB, Abdennebi YB, Ali ZB, Abid HB, Meddeb B. Kacem K, et al. Among authors: meddeb b. Turk J Haematol. 2014 Jun;31(2):188-91. doi: 10.4274/tjh.2012.0125. Epub 2014 Jun 10. Turk J Haematol. 2014. PMID: 25035679 Free PMC article.
Multiple myeloma with Auer-rod-like inclusions.
Fekih Salem S, Borgi WE, BenLakhal F, Kefi S, Meddeb M, Meddeb B, Gouider E. Fekih Salem S, et al. Among authors: meddeb b. Ann Biol Clin (Paris). 2021 Jun 1;79(3):253-256. doi: 10.1684/abc.2021.1645. Ann Biol Clin (Paris). 2021. PMID: 34159906 Free article. No abstract available.
Factor XI deficiency: About 20 cases and literature review.
Dhaha Y, El Borgi W, Elmahmoudi H, Achour M, Fekih Salem S, Ben Lakhal F, Meddeb B, Gouider E. Dhaha Y, et al. Among authors: meddeb b. Tunis Med. 2022 Janvier;100(1):60-65. Tunis Med. 2022. PMID: 35822334 Free PMC article. Review.
[Thalassemia intermedia: 36 cases].
Hafsia R, Ben Salah N, Hafhouf E, Belakhal F, Gouider E, El Borji W, Meddeb B. Hafsia R, et al. Among authors: meddeb b. Tunis Med. 2010 Feb;88(2):102-4. Tunis Med. 2010. PMID: 20415168 Free article. French.
Tunisian adult's Hodgkin lymphoma Study Group.
Ben Lakhal R, Hdiji S, Ben Youssef Y, Laariri MA, Zriba S, Toumi N, Mokrani A, Ezzaier F, Ladb S, Frikha H, Mesai T, Ben Salah H, Tebra S, Daoued J, Bouaouina N, Maalej M, Frikha M, Ben Ahmed S, Mezlini A, Ben Othmen T, Msaddek F, Khelif A, Elloumi M, Meddeb B. Ben Lakhal R, et al. Among authors: meddeb b. Tunis Med. 2016 Nov;94(11):706. Tunis Med. 2016. PMID: 28994864 Free article.
Low dose prophylaxis in Tunisian children with haemophilia.
Gouider E, Jouini L, Achour M, Elmahmoudi H, Zahra K, Saied W, Meddeb B. Gouider E, et al. Among authors: meddeb b. Haemophilia. 2017 Jan;23(1):77-81. doi: 10.1111/hae.13048. Epub 2016 Dec 11. Haemophilia. 2017. PMID: 27943510
Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma.
Robak T, Huang H, Jin J, Zhu J, Liu T, Samoilova O, Pylypenko H, Verhoef G, Siritanaratkul N, Osmanov E, Alexeeva J, Pereira J, Drach J, Mayer J, Hong X, Okamoto R, Pei L, Rooney B, van de Velde H, Cavalli F; LYM-3002 Investigators. Robak T, et al. N Engl J Med. 2015 Mar 5;372(10):944-53. doi: 10.1056/NEJMoa1412096. N Engl J Med. 2015. PMID: 25738670 Free article. Clinical Trial.
93 results